to perform due to blood that obscures the mucosa as it refluxes throughout the colon, even if it originates from a distal site. Alternatives for diagnosis and therapy include radiological and surgical interventions, which are often used for acute, severe hemorrhage but carry considerable morbidity and mortality (1, 2) . Despite numerous advances in diagnostic strategies over the past several decades, as many as 8% to 12% of patients with acute, severe LGI bleeding still undergo surgery without localization of the bleeding site. Up to 33% of patients continue to bleed postoperatively (3) (4) (5) . Furthermore, LGI bleeding tends to be intermittent, with 85% of patients undergoing spontaneous cessation (6, 7) ; this creates difficulty in assessing clinical outcomes because the majority of patients stop bleeding regardless of therapeutic intervention. Finally, ready access to emergency colonoscopy is not universal, and with evertighter financial constraints, endoscopy units are under increased pressure to meet budgetary demands by restricting the number of endoscopic procedures. This pressure may encourage some gastroenterologists (who would otherwise use emergency endoscopy) to opt instead for an alternative mode of investigation and management.
Although consensus guidelines (8) , and recommendations for investigation and management of LGI bleeding exist (3, (9) (10) (11) (12) (13) (14) , there is no universally accepted method that applies to all patients. The present article offers a review of the published literature in an effort to assist endoscopists with their management of patients with LGI bleeding, with an emphasis on assessment and treatment of massive LGI bleeding, and to develop further practice guidelines for management.
The most important initial step in assessing a patient with LGI bleeding is the history and physical examination. Clearly, the accurate, expedient assessment of the airway, breathing and circulation guides the speed at which resuscitation is initiated. At times, the clinical presentation of UGI bleeding can be identical to that of LGI bleeding; therefore, use of nonsteroidal anti-inflammatory drugs, or a history of peptic ulcer disease, dyspepsia or liver disease may dramatically change the sequence of investigations. Similarly, a change of bowel habits, anorectal complaints or a history of hematochezia can alter the course of investigations if noted. The assessment of hemodynamic stability and the estimation of the amount of blood loss are the next steps. Adequate intravenous access of crystalloid and colloid should be administered to all patients with suspected moderate or massive gastrointestinal bleeding. If there is any suspicion of UGI bleeding resulting in hematochezia, insertion of a nasogastric tube or even an upper endoscopy may be warranted to identify the bleeding site. In certain instances, proctoscopic examination is indicated for the assessment and subsequent treatment of hemorrhoids, which occasionally can present with severe bleeding.
CLINICAL PRESENTATION OF LGI BLEEDING
The timing and type of gastrointestinal investigations depend primarily on the type of LGI bleeding.
There are three clinical presentations of LGI bleeding to consider, as follow:
• Hemoccult (Beckman Coulter Inc, USA)-positive stools, found as part of an outpatient investigation or screening examination. These patients tend to have chronic blood loss, which can be investigated on an outpatient basis. Sometimes both UGI and LGI tract investigations are required to clarify the source of bleeding, because positivity on Hemoccult may result from bleeding either proximal or distal to the ligament of Treitz.
• Passage of minimal amounts of bright red blood per rectum. This problem can often be clarified by an appropriate history and a careful perianal examination. Typically, the cause is an anal fissure, hemorrhoids or other distal colonic lesions. Proctoscopy combined with flexible or rigid sigmoidoscopy, in most cases on an elective basis, is usually sufficient to diagnose the problem.
• Massive LGI blood loss. Hematochezia is a term derived from the Greek haimatos, meaning 'blood' and chezein meaning 'to go to stool' (15) . Massive LGI blood loss is arbitrarily defined as bleeding below the ligament of Treitz that is severe enough to require blood transfusions of 3 to 5 U to maintain hemodynamic stability. This definition is somewhat controversial because different studies have used different criteria. Other definitions include hematocrit under 30%, any orthostatic changes in blood pressure and a requirement for any quantity of transfused blood associated with the passage of bright red blood per rectum (16) . ETIOLOGY Massive hematochezia typically occurs in elderly patients (average 60 years of age) (17) . It carries a mortality rate of up to 30% (7, (18) (19) (20) and accounts for about 0.7% of all dis- (Table 3 ) (24) . Most evaluations of massive LGI bleeding are single-centre studies based on relatively small numbers of cases; the data often reflect referral, diagnostic and treatment biases existing at local institutions. Nonetheless, when the data of several studies are combined, the results suggest that the most common cause of massive LGI bleeding is likely diverticulosis, which accounts for approximately 30% to 40% of all cases (4, 22, (24) (25) (26) (27) (28) . Although arteriovenous malformations account for only 2% of all LGI bleeding (22) , they account for 15% to 30% of massive gastrointestinal hemorrhage (3, (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) . Other causes of massive LGI bleeding include (in order of decreasing frequency) cancer, polyps, inflammatory bowel disease and ischemia.
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SPECIFIC CAUSES OF LGI BLEEDING Colonic diverticulosis:
Colonic diverticula are defined as false, pulsion diverticula because they consist of mucosa and serosa. Although more than 50% (34) of all people over age 60 years have radiological evidence of diverticula, only 20% (35) experience bleeding. Of these people, 80% will stop bleeding spontaneously, 35% will require transfusion or invasive diagnostic/therapeutic intervention and 5% will have massive hemorrhage and ultimately require an emergency operation (5, (35) (36) (37) (38) (39) . Diverticula are believed to originate when increased luminal pressure causes a segment of the mucosa to extrude through weaker areas of the muscularis mucosa. The muscularis mucosa tends to be weaker in sites where there are penetrating arterial vasa recta. Meyers et al (40) postulated that injurious factors arising within the colonic or diverticular lumen damage the luminal side of the underlying vas rectum, resulting in weakening of the arterial wall at this site. This theory is supported by histopathological lesions seen in the vasa recta such as intimal thickening, duplication of the internal elastic lamina and thinning of the media.
Bleeding associated with diverticulitis tends to be mild and stems from mucosal inflammation in the region of the inflamed diverticulum (40) . Conversely, bleeding from diverticulosis tends to be sudden and significant because it originates from an arterial source. If bleeding is recurrent and mild, one should ensure that other sources of bleeding, such as polyps and cancer, have been excluded. As noted above, most diverticular bleeding ceases spontaneously. Unfortunately, 25% of patients who have diverticular bleeding experience a second episode, and of these patients, more than 50% will bleed again if definitive therapy is not initiated (3, 5) .
Although most diverticula are located distal to the splenic flexure, 60% of those found to be bleeding at mesenteric angiography are located proximal to the splenic flexure (23) . It is often mistakenly stated and believed that the bleeding is from diverticula (ie, multiple sites), when a single diverticulum is usually responsible for the bleeding, regardless of the number of diverticula. It is unclear why bleeding appears to be more common from right-sided than from left-sided colonic diverticula.
Treatment for recurrent bleeding (usually after the second mild to moderate episode) or for persistent bleeding from a diverticular source is traditionally surgical. Diagnostic studies are required to identify the site of colonic bleeding in an effort to guide the surgical resection. Endoscopic therapy can help identify the site in some patients and, in a select group, treat the bleeding. Although endoscopic electrocoagulation of a thin-walled diverticulum has been considered to carry a high risk, a recent small series reported success in three patients without complication (41, 42) . These patients had had recurrent bleeding from a diverticulum and were found to have a visible vessel at the edge of a diverticulum. They were treated with gold probe electrocautery, using a 50 W generator with a power setting of 20 W. The patients were managed on bulk agents and followed for a median of three years, with no evidence of rebleeding.
Other endoscopic options include target suctioning (43) and selective adrenaline injection into the base and sides of the diverticulum (44) . Induced vasoconstriction, in addi- (48), using operative mesenteric arteriography, discovered the presence of these vascular bleeding lesions. Since that time, the use of angiography (17, 49) and colonoscopy (17, (48) (49) (50) (51) (52) (53) (54) has identified them as a significant cause of gastrointestinal hemorrhage. AVMs are seen most commonly in the right colon and cecum (3), and occur with increasing frequency with advancing age. Although the mean age of symptomatic patients is 70 years, 2% to 30% of the population older than 50 years harbour these lesions (17, (55) (56) (57) (58) (59) (60) . They are degenerative lesions believed to originate from chronic, partial obstruction of submucosal veins with subsequent capillary dilation and damage to capillary sphincters, ultimately resulting in incompetence and finally arteriovenous connections (17, 61) . This theory fits clinically because most angiodysplastic lesions are found in the cecum, which, due to its larger relative diameter, must exhibit greater wall tension (Laplace's Law) (3, (62) (63) (64) . Approximately 70% of symptomatic angiodysplastic lesions occur in the right colon (33% in the cecum, 39% in the hepatic flexure or ascending colon), with the sigmoid (22%) and transverse colon (6%) being affected less frequently (33, 65) .
Most (70%) colonic AVMs present with chronic, slow, intermittent and recurrent bleeding rather than hematochezia (25, 66) . Their importance in patients with massive LGI bleeding varies depending on the study reviewed. Although AVMs are responsible for only 2% of all LGI bleeding, they account for up to 30% of all episodes of massive LGI bleeding (3, 22, (25) (26) (27) (28) (29) (30) (31) (32) . Most of these lesions are less than 5 mm in diameter, with only 2% being larger than 20 mm (24, 33) . Their small size may contribute to the difficulty in establishing a diagnosis. Indeed, many patients experience three to five episodes of bleeding before the diagnosis is made (67) (68) (69) . Associated heart disease, most commonly aortic stenosis, is found in about 50% of patients (24) . This association has been explored by several investigators, but the relationship between aortic stenosis and angiodysplastic lesions remains unclear (56, (70) (71) (72) . Both disorders are known to occur with increasing age; thus, age alone may account for the apparent increased incidence of angiodysplasia in these patients (3, 27) . Others have postulated that, although there is not a true increased incidence of angiodysplastic lesions in patients with aortic stenosis, the lesions that are present may simply have an increased propensity to bleed. This theory stems from the postulate that aortic stenosis causes a low perfusion state that leads to "ischemic necrosis of the single layer of endothelium which often separates ectatic vessels from the colonic lumen", resulting in LGI hemorrhage (73) . Other disease associations with angiodysplasia include cirrhosis, chronic renal failure, prior abdominal radiation therapy and collagen vascular disease.
Endoscopic therapy, once reserved for high risk patients, is now considered to be standard practice for these lesions. Once the lesion has been identified, endoscopic therapy may involve heater probe, bipolar and monopolar electrode, argon plasma coagulation and laser (74) . Several studies evaluating endoscopic electrocoagulation have found success rates ranging from 70% to 80% (33, 50, 56) . The largest series evaluated was from the Center for Ulcer Research and Education (CURE) Hemostasis Research Group, which enrolled 100 patients with bleeding from colonic angiomata in a long term prospective study over two years. The mean number of colonoscopic treatments was 1.4 (range one to four), with endoscopic coagulation (bipolar or heater probe) performed on 716 colonic angiomas (mean seven per session, range one to 48). When comparing endoscopic treatment with medical treatment (the two years before endoscopic diagnosis), significant decreases were seen in the number of LGI bleeding episodes per year (1.3/year compared with 0.6/year) and number of units of red blood cell transfusions (4.3/year compared with 1.3/year). Similarly, there was significant improvement in hematocrit, which rose from 26.8% before colonoscopic therapy to 37.3% after therapy. During long term follow-up, 18% of patients required surgical intervention (usually a right hemicolectomy); 39% of these patients continued to have recurrent bleeding after their surgeries. Interestingly, this included four patients with renal failure and one who was taking anticoagulants for cardiac valvular disease (33) . Earlier studies on angiodysplastic lesions did not demonstrate such a high recurrent bleeding rate postoperatively, although some patients did have coagulation defects (75) .
Complication rates of endoscopic therapy of angiodysplastic lesions range from 4% to 7%, with more complications occurring in patients who undergo heater probe treatment (7%), as opposed to bipolar electrocoagulation (4%). Cecal lesions may have a slightly increased rate of complications secondary to decreased wall thickness that makes it more susceptible to perforation. Delayed rebleeding appears to be more common in patients with abnormal platelet function and those with giant angiomata. These patients often require surgical intervention (33) .
For patients with recurrent bleeding who have lesions that are difficult to treat, are too numerous to be treated with endoscopic therapy or that are presumed to be located within the small intestine, adjunctive therapy with estrogens is suggested. By improving the vascular endothelium and possibly having a primary benefit on coagulation, oral estrogens have been shown to decrease bleeding in select patients, such as those with hereditary hemorrhagic telangiectasia or chronic renal failure (76).
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'Blind hemicolectomy' is rarely indicated in LGI bleeding. The mortality rate associated with surgical resection ranges from 10% to 50% (2, 17, 56, 75) . This higher risk results from patients who tend to be elderly with multiple coexisting medical problems, including coronary artery disease. Because involvement of small bowel or bilateral colonic angiodysplastic lesions is common, accurate identification of the bleeding site is critical when surgical intervention is being considered (50, 75) . Neoplasms: Occult rectal bleeding and the passage of bright red blood per rectum are typical presentations of adenomatous polyps and adenocarcinomas of the colon and rectum. Severe hematochezia, however, is relatively uncommon. Conflicting reports of incidence likely result from referral bias. Rossini et al (28) reported that 32% of patients with massive colonic bleeding had ulcerated carcinomas or polyps, while Jensen and Machicado (33) reported it as a cause in only 11% of patients. The true incidence is likely somewhere in between (4, 7, 16, 20, 25, 27, 63, 77) . Polyps and small cancers are amenable to endoscopic therapy, but most cancers require surgical intervention.
Bleeding is the most common complication after colonoscopic polypectomy. Immediate bleeding (often easily controlled at the time of endoscopy) occurs in up to 3% of cases (78, 79) , delayed polypectomy hemorrhage occurs in up to 0.3% (1, (80) (81) (82) (83) . Treatment of early and late postpolypectomy bleeding is usually endoscopic, with identification of the bleeding stalk being of paramount importance. Grasping the stalk with a snare and recauterizing or simply closing the snare around the stalk for a period of time is usually sufficient to allow a coagulum to form. Other methods of therapy include cauterization and, for patients in whom endoscopic therapy fails, angiographic embolization and surgical resection have been successfully reported (82) . If the bleeding appears to be coming from an induced ulcer postpolypectomy, treatment would include injection of adrenaline and the use of the heater or bipolar probe. Lower power settings and light tamponade are recommended. Neodymium:yttrium-aluminum-garnet laser and monopolar electrocoagulation are not recommended in the treatment of these ulcerations because of the possibility of transmural injury (33) . In the case of delayed hemorrhage, other sites of bleeding must always be considered preoperatively. If there is any doubt regarding the site of bleeding, a complete colonoscopy must be performed. Inflammatory bowel disease: Despite that ulcerative colitis and Crohn's disease are characterized by bleeding and diarrhea, massive hematochezia is uncommon, occurring in only 3% to 5% of all patients with massive LGI bleeding (16, 20, 84, 85) . Up to 6% of patients with Crohn's disease or ulcerative colitis experience severe LGI bleeding (86, 87) . The incidence may be slightly higher in Crohn's disease, secondary to the transmural nature of the disorder (21) . In Crohn's disease, the distribution of bleeding reflects the frequency with which an area of the bowel is affected, with the ileum being the most commonly affected. Most patients with Crohn's disease who present with massive hematochezia are known to have had Crohn's disease for at least several years (88) . Medical therapy is usually the initial treatment choice because therapy for the underlying disorder may result in control of hemorrhage. Unfortunately, although 50% of patients stop bleeding spontaneously, 35% will rebleed; thus, an urgent colectomy is recommended for patients with colitis who suffer a life-threatening hemorrhage (1, 33, 86, 87) . Proctectomy is reserved for patients in whom the rectum is the primary site of bleeding. In ulcerative colitis, colectomy and end ileostomy with preservation of the rectal stump (to allow elective proctectomy and construction of an ileoanal reservoir at a later date) are recommended methods of resection; in Crohn's colitis, colectomy with ileoproctostomy (provided that the rectum is not inflamed or not the site of bleeding) is recommended (21, 89) . Focal ulceration: Focal ulceration with severe hemorrhage is a rare cause of massive LGI bleeding. This ulceration may arise from inflammatory bowel disease or after polypectomy, as discussed above, or from infection or ischemia.
Typical infections include cytomegalovirus (in immunocompromised patients) and pseudomembranous colitis. These infections are often first suspected at clinical presentation because both are usually accompanied by diarrhea, and are associated with either immune suppression or recent antibiotic exposure. Other infections, such as amebiasis, have occasionally been reported to cause severe gastrointestinal hemorrhage (90) . Treatment is directed at the underlying cause of the bleeding, not necessarily at the bleeding itself. If endoscopic therapy is attempted, it should be performed only after failure of medical treatment. These bleeding lesions can be treated with a combination of adrenaline injection with or without the use of bipolar probe. Extreme caution must be employed because the colonic wall of these lesions is typically thin and easily perforated. Some patients require colectomy for definitive therapy. Cold guillotining-off of adherent clots, as performed in UGI ulcers, has been suggested by Jensen and Machicado (33) for focal colonic ulcers with adherent clots.
Although bloody diarrhea is common with ischemic colitis, significant LGI hemorrhage is unusual (21, 91, 92) . Different types of ischemic episodes must be considered. Acute occlusive ischemic mesenteric episodes usually present as pain and, therefore, are seldom confused with other more common causes of LGI hemorrhage. Presentation is sudden and severe; the patient often has a history of cardiac disease. Nonocclusive types of acute ischemia present with vague and nonspecific symptoms but rarely significant LGI hemorrhage. Early angiography and surgical intervention improve the opportunity for intestinal salvage (3, 17, 19, 82, 93) . Chronic ischemia involving the small bowel may present with diarrhea secondary to malabsorption, but because only 5% of patients with colonic ischemia experience recurrent episodes, chronic colonic ischemia is rare (82) .
The use of nonsteroidal anti-inflammatory drugs (NSAIDs) has been shown to result in significant morbid-ity from deleterious effects on the UGI tract, but their effect on the LGI tract is often forgotten. Profuse diarrhea, chronic blood loss, iron deficiency anemia and increased risk of bleeding from diseased regions (eg, diverticula) have all been attributed to NSAID use (25, 94, 95) . NSAIDs may increase the risk of bleeding in patients with known abnormalities within the colon through platelet inhibition. Patients with any history of gastrointestinal hemorrhage, including colonic, should be cautioned regarding the use of these drugs. Anorectal disease: Although hemorrhoids are the most common source of LGI bleeding (21, 25, 92, 93, 95) , massive ongoing bleeding is distinctly unusual. Recurrent bleeding can occasionally lead to iron deficiency with subsequent microcytic anemia (96) . Rarely, hemorrhoids may bleed profusely and require urgent surgical intervention. It is imperative to rule out perianal bleeding before pursuing other more complex and invasive investigations for LGI hemorrhage. This is usually satisfactorily done with a rectal examination combined with either proctoscopy or sigmoidoscopy.
Anorectal, colonic and peristomal varices can cause severe, painless massive LGI hemorrhage. Although usually caused by cirrhosis complicated by portal hypertension, they can also result from severe congestive heart failure, portal vein thrombosis and congenital abnormalities of the mesenteric venous system (97, 98) . Anorectal varices may be present in up to 89% of patients with portal hypertension. They are best diagnosed endoscopically. Definitive treatment may require portal decompression (surgical or transjugular) or, in appropriate patients, liver transplantation. Bleeding from anorectal and peristomal varices can often be controlled with injection sclerotherapy. There may also be a role for endoscopic banding. Colectomy for bleeding varices is associated with high mortality (90%) and should be avoided (97, (99) (100) (101) (102) (103) . Other sources of gastrointestinal hemorrhage: The UGI tract should always be considered in patients presenting with bright red blood per rectum. Approximately 10% to 15% of cases of acute rectal bleeding have a UGI source (104) . If an upper endoscopy and an evaluation of the colon are both negative, the small bowel should also be considered as a possible source of bleeding. It is responsible for 3% to 5% of LGI bleeding episodes (27, 77, 105, 106) . Specific diagnosis and localization are often difficult because of the small bowel length, redundancy, tortuosity and general inaccessibility. Angiodysplasia accounts for 70% to 80% of small bowel hemorrhage with other diagnoses, including jejunoileal diverticula (105,107), Meckel's diverticulum (63) , neoplasia (benign and malignant), enteritis and aortoenteric fistula (56, 89, 105, 108) .
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